Abstract
Three types of models used to represent the object of control in anticancer therapies are presented. The first approach is based on the idea that chemotherapy may be treated as control action with cell-cycle as an object of control. In the second approach population dynamics models are used to describe anticancer treatment in antiangiogenic and combined therapies. The last level on which we consider control problems resulting from anticancer actions is related to gene signaling pathway models. In this case we propose the use of interfering RNA to aid radiotherapy by silencing the negative feedback in p53 protein regulatory module.
| Original language | English |
|---|---|
| Title of host publication | 2012 17th International Conference on Methods and Models in Automation and Robotics, MMAR 2012 |
| Pages | 421-426 |
| Number of pages | 6 |
| DOIs | |
| Publication status | Published - 2012 |
| Event | 2012 17th International Conference on Methods and Models in Automation and Robotics, MMAR 2012 - Miedzyzdroje, Poland Duration: 27 Aug 2012 → 30 Aug 2012 |
Publication series
| Name | 2012 17th International Conference on Methods and Models in Automation and Robotics, MMAR 2012 |
|---|
Conference
| Conference | 2012 17th International Conference on Methods and Models in Automation and Robotics, MMAR 2012 |
|---|---|
| Country/Territory | Poland |
| City | Miedzyzdroje |
| Period | 27/08/12 → 30/08/12 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Artificial Intelligence
- Human-Computer Interaction
Fingerprint
Dive into the research topics of 'Three levels of objects of control in anticancer therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver